Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2014 (2014), Article ID 539854, 5 pages
http://dx.doi.org/10.1155/2014/539854
Research Article

Comparison of Antioxidant Status and Vitamin D Levels between Multiple Sclerosis Patients and Healthy Matched Subjects

1Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Tehran, Iran
2Department of Nutrition, School of Para Medicine, Diabetes Research Center, Jundishapur University of Medical Sciences, Ahvaz 61357-15794, Iran
3Department of Neurology, Golestan Hospital, Jundishapur University of Medical Sciences, Ahvaz, Iran
4Department of Epidemiology, School of Public Health, Jundishapur University of Medical Sciences, Ahvaz, Iran

Received 16 January 2014; Revised 25 February 2014; Accepted 24 March 2014; Published 14 April 2014

Academic Editor: Wolfgang Bruck

Copyright © 2014 Ehsan Hejazi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Shaygannejad, M. Janghorbani, F. Ashtari, and H. Dehghan, “Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial,” Multiple Sclerosis International, vol. 2012, Article ID 452541, 7 pages, 2012. View at Publisher · View at Google Scholar
  2. S. Katsavos and M. Anagnostouli, “Biomarkers in multiple sclerosis: an up-to-date overview,” Multiple Sclerosis International, vol. 2013, Article ID 340508, 20 pages, 2013. View at Publisher · View at Google Scholar
  3. R. Furlan, M. Rovaris, F. M. Boneschi et al., “Immunological patterns identifying disease course and evolution in multiple sclerosis patients,” Journal of Neuroimmunology, vol. 165, no. 1-2, pp. 192–200, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Correale, M. C. Ysrraelit, and M. I. Gaitn, “Immunomodulatory effects of vitamin D in multiple sclerosis,” Brain, vol. 132, part 5, pp. 1146–1160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. I. A. F. van der Mei, A. Ponsonby, T. Dwyer et al., “Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study,” The British Medical Journal, vol. 327, no. 7410, pp. 316–320, 2003. View at Google Scholar · View at Scopus
  6. K. L. Munger, S. M. Zhang, E. O'Reilly et al., “Vitamin D intake and incidence of multiple sclerosis,” Neurology, vol. 62, no. 1, pp. 60–65, 2004. View at Google Scholar · View at Scopus
  7. J. M. Lemire and D. C. Archer, “1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis,” Journal of Clinical Investigation, vol. 87, no. 3, pp. 1103–1107, 1991. View at Google Scholar · View at Scopus
  8. M. T. Cantorna, C. E. Hayes, and H. F. Deluca, “1,25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 15, pp. 7861–7864, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Ferretti, T. Bacchetti, F. Principi et al., “Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity,” Multiple Sclerosis, vol. 11, no. 6, pp. 677–682, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. M. Zhang, M. A. Hernán, M. J. Olek, D. Spiegelman, W. C. Willett, and A. Ascherio, “Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women,” Neurology, vol. 57, no. 1, pp. 75–80, 2001. View at Google Scholar · View at Scopus
  11. E. Miller, M. Mrowicka, K. Malinowska, J. Mrowicki, J. Saluk-Juszczak, and J. Kȩdziora, “Effects of whole-body cryotherapy on a total antioxidative status and activities of antioxidative enzymes in blood of depressive multiple sclerosis patients,” World Journal of Biological Psychiatry, vol. 12, no. 3, pp. 223–227, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Acar, M. U. Cevik, O. Evliyaoglu et al., “Evaluation of serum oxidant/antioxidant balance in multiple sclerosis,” Acta Neurologica Belgica, vol. 112, no. 3, pp. 275–280, 2012. View at Publisher · View at Google Scholar
  13. C. H. Polman, S. C. Reingold, G. Edan et al., “Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald criteria’,” Annals of Neurology, vol. 58, no. 6, pp. 840–846, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Lips, “Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications,” Endocrine Reviews, vol. 22, no. 4, pp. 477–501, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. N. J. Miller, C. Rice-Evans, M. J. Davies, V. Gopinathan, and A. Milner, “A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates,” Clinical Science, vol. 84, no. 4, pp. 407–412, 1993. View at Google Scholar · View at Scopus
  16. S. Hashemipour, B. Larijani, H. Adibi et al., “Vitamin D deficiency and causative factors in the population of Tehran,” BMC Public Health, vol. 4, article 38, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Shaygannejad, K. Golabchi, S. Haghighi, H. Dehghan, and A. Moshayedi, “A comparative study of 25 (OH) vitamin D serum levels in patients with multiple sclerosis and control group in Isfahan, Iran,” International Journal of Preventive Medicine, vol. 1, no. 3, pp. 195–201, 2010. View at Google Scholar · View at Scopus
  18. S. Ozgocmen, S. Bulut, N. Ilhan, A. Gulkesen, O. Ardicoglu, and Y. Özkan, “Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity,” Journal of Bone and Mineral Metabolism, vol. 23, no. 4, pp. 309–313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. B. D. Mahon, S. A. Gordon, J. Cruz, F. Cosman, and M. T. Cantorna, “Cytokine profile in patients with multiple sclerosis following vitamin D supplementation,” Journal of Neuroimmunology, vol. 134, no. 1-2, pp. 128–132, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Soilu-Hänninen, L. Airas, I. Mononen, A. Heikkilä, M. Viljanen, and A. Hänninen, “25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis,” Multiple Sclerosis, vol. 11, no. 3, pp. 266–271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. I. A. F. van der Mei, A. Ponsonby, T. Dwyer et al., “Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia,” Journal of Neurology, vol. 254, no. 5, pp. 581–590, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Simpson Jr., B. Taylor, L. Blizzard et al., “Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis,” Annals of Neurology, vol. 68, no. 2, pp. 193–203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. H. Gannage-Yared, R. Chemali, N. Yaacoub, and G. Halaby, “Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers,” Journal of Bone and Mineral Research, vol. 15, no. 9, pp. 1856–1862, 2000. View at Google Scholar · View at Scopus
  24. C. Berr, J. Puel, M. Clanet, J. B. Ruidavets, J. L. Mas, and A. Alperovitch, “Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrenees, France,” Acta Neurologica Scandinavica, vol. 80, no. 1, pp. 46–50, 1989. View at Google Scholar · View at Scopus
  25. A. Antonovsky, U. Leibowitz, H. A. Smith et al., “Epidemiologic study of multiple sclerosis in Israel. I. An overall review of methods and findings,” Archives of Neurology, vol. 13, pp. 183–193, 1965. View at Google Scholar · View at Scopus
  26. S. M. Zhang, W. C. Willett, M. A. Hernán, M. J. Olek, and A. Ascherio, “Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women,” The American Journal of Epidemiology, vol. 152, no. 11, pp. 1056–1064, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Nakamura, M. Nashimoto, Y. Hori, and M. Yamamoto, “Serum 25-hydroxyvitamin D concentrations and related dietary factors in peri- and postmenopausal Japanese women,” The American Journal of Clinical Nutrition, vol. 71, no. 5, pp. 1161–1165, 2000. View at Google Scholar · View at Scopus
  28. A. Visconti, R. Cotichini, S. Cannoni et al., “Concentration of elements in serum of patients affected by multiple sclerosis with first demyelinating episode: a six-month longitudinal follow-up study,” Annali dell'Istituto Superiore di Sanita, vol. 41, no. 2, pp. 217–222, 2005. View at Google Scholar · View at Scopus
  29. H. T. Besler and S. Çomoǧlu, “Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis,” Nutritional Neuroscience, vol. 6, no. 3, pp. 189–196, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. M. W. Koch, G. S. M. Ramsaransing, A. V. Arutjunyan et al., “Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis,” Journal of Neurology, vol. 253, no. 4, pp. 483–487, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Toncev, B. Milicic, S. Toncev, and G. Samardzic, “Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction,” European Journal of Neurology, vol. 9, no. 3, pp. 221–226, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. H. T. Besler, S. Omoǧlu, and Z. Oku, “Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis,” Nutritional Neuroscience, vol. 5, no. 3, pp. 215–220, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Farinotti, L. Vacchi, S. Simi, C. Di Pietrantonj, L. Brait, and G. Filippini, “Dietary interventions for multiple sclerosis,” Cochrane Database of Systematic Reviews, vol. 12, Article ID CD004192, 2012. View at Publisher · View at Google Scholar